Literature DB >> 26096484

Can patient characteristics predict benefit from epidural corticosteroid injections for lumbar spinal stenosis symptoms?

Judith A Turner1, Bryan A Comstock2, Christopher J Standaert3, Patrick J Heagerty2, Jeffrey G Jarvik4, Richard A Deyo5, Ajay D Wasan6, Srdjan S Nedeljkovic7, Janna L Friedly3.   

Abstract

BACKGROUND CONTEXT: Epidural corticosteroid injections are commonly used to treat back and leg pain associated with lumbar spinal stenosis. However, little is known about which patient characteristics may predict favorable responses.
PURPOSE: The aim was to identify patient characteristics associated with benefits from epidural injections of corticosteroid with lidocaine versus epidural injections of lidocaine only for lumbar spinal stenosis symptoms. STUDY DESIGN/
SETTING: This was a secondary analysis of Lumbar Epidural steroid injections for Spinal Stenosis randomized controlled trial data from 16 US clinical sites. PATIENT SAMPLE: Patients aged older than or equal to 50 years with moderate-to-severe leg pain and lumbar central spinal stenosis randomized to epidural injections of corticosteroids with lidocaine (n=200) or lidocaine only (n=200) were included. OUTCOME MEASURES: Primary outcomes were the Roland-Morris Disability Questionnaire (RMDQ) and 0 to 10 leg pain intensity ratings. Secondary outcomes included the Brief Pain Inventory Interference Scale and the Swiss Spinal Stenosis Questionnaire.
METHODS: At baseline, clinicians rated severity of patient spinal stenosis, and patients completed predictor and outcome measures. Patients completed outcome measures again 3 and 6 (primary end point) weeks after randomization/initial injection. Analysis of covariance was used with treatment by covariate interactions to identify baseline predictors of greater benefit from corticosteroid+lidocaine versus lidocaine alone. We also identified nonspecific (independent of treatment) predictors of outcomes.
RESULTS: Among 21 candidate predictors and six outcomes, only one baseline variable predicted greater benefit from corticosteroid+lidocaine versus lidocaine only at 3 or 6 weeks. Compared with patients who rated their health-related quality of life as high on the EQ-5D Index, patients who rated it as poor had greater improvement with corticosteroid than with lidocaine only in leg pain at 6 (but not 3) weeks (interaction coefficient=2.94; 95% confidence interval [CI]=0.11-5.76; p=.04) and in RMDQ disability scores at 3 (but not 6) weeks (interaction coefficient=4.77, 95% CI= -0.04 to 9.59; p = .05). Several baseline patient characteristics predicted outcomes regardless of treatment assignment.
CONCLUSIONS: Among 21 baseline patient characteristics examined, none, including clinician-rated spinal stenosis severity, were consistent predictors of benefit from epidural injections of lidocaine+corticosteroid versus lidocaine only.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Back pain; Corticosteroid; Epidural steroid injections; Leg pain; Lumbar spinal stenosis; Predictors; Treatment effect modifiers

Mesh:

Substances:

Year:  2015        PMID: 26096484     DOI: 10.1016/j.spinee.2015.06.050

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  5 in total

1.  Cost-effectiveness of conservative versus surgical treatment strategies of lumbar spinal stenosis in the Swiss setting: analysis of the prospective multicenter Lumbar Stenosis Outcome Study (LSOS).

Authors:  A Aichmair; J M Burgstaller; M Schwenkglenks; J Steurer; F Porchet; F Brunner; M Farshad
Journal:  Eur Spine J       Date:  2016-12-31       Impact factor: 3.134

2.  Lumbar Spinal Stenosis Severity by CT or MRI Does Not Predict Response to Epidural Corticosteroid versus Lidocaine Injections.

Authors:  F A Perez; S Quinet; J G Jarvik; Q T Nguyen; E Aghayev; D Jitjai; W D Hwang; E R Jarvik; S S Nedeljkovic; A L Avins; J M Schwalb; F E Diehn; C J Standaert; D R Nerenz; T Annaswamy; Z Bauer; D Haynor; P J Heagerty; J L Friedly
Journal:  AJNR Am J Neuroradiol       Date:  2019-05-02       Impact factor: 3.825

3.  Validation of a novel range of motion assessment tool for the cervical spine: the HALO© digital goniometer.

Authors:  Ashley R Wilson-Smith; Saimurooban Muralidaran; Monish Maharaj; Matthew H Pelletier; Peter Beshara; Prashanth Rao; Louise M Pearce; Tian Wang; Ralph J Mobbs; William R Walsh
Journal:  J Spine Surg       Date:  2022-03

4.  Association of Protein and Genetic Biomarkers With Response to Lumbar Epidural Steroid Injections in Subjects With Axial Low Back Pain.

Authors:  Stephen Schaaf; Wan Huang; Subashan Perera; Yvette Conley; Inna Belfer; Prakash Jayabalan; Katie Tremont; Paulo Coelho; Sara Ernst; Megan Cortazzo; Debra Weiner; Nam Vo; James Kang; Gwendolyn Sowa
Journal:  Am J Phys Med Rehabil       Date:  2021-01-01       Impact factor: 3.412

Review 5.  The influence of comorbidities on the treatment outcome in symptomatic lumbar spinal stenosis: A systematic review and meta-analysis.

Authors:  Amandine Bays; Andrea Stieger; Ulrike Held; Lisa J Hofer; Eva Rasmussen-Barr; Florian Brunner; Johann Steurer; Maria M Wertli
Journal:  N Am Spine Soc J       Date:  2021-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.